Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:51 PM
Ignite Modification Date:
2025-12-24 @ 3:51 PM
NCT ID:
NCT03453892
Eligibility Criteria:
Inclusion Criteria:
* Patients suffering and diagnosed for: metastatic cancer of several entities
* Clinical indicated therapy with PD-1/PD-L1 inhibitors or CTLA-4 antagonists
* Optionally radiotherapy if clinically indicated
* Age at least 18 years
Exclusion Criteria:
* fertile patients who refuse effective contraception during study treatment
* persistent drug and/or alcohol abuse
* patients not able or willing to behave according to study protocol
* patients in care
* patients that are not able to speak German
* patients which are imprisoned according to legal or governmental order
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03453892
Study Brief:
Protocol Section:
NCT03453892